Addressing Cardiovascular Risk and Intervening Early
Join us for a free, live webinar as experts dive into the current state of cardiovascular disease in the US, traditional and emerging risk factors, and the critical role of prevention.
Latest News
View All
Basophil, Eosinophil Counts Could Be Prognostic Indicators in ET, PV
Approved Hidradenitis Suppurativa Treatments and Pipeline Show Similar Efficacy, Safety Without Head-to-Head Trials
Racial Disparities in Opioid Use Disorder Treatment After ED Visit for Overdose
Tear Film Instability More Severe in Patients With Dry Eye, Diabetes
Racial Disparities in Opioid Use Disorder Treatment After ED Visit for Overdose
Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bob, MPH
Health Equity Challenges in Community Oncology: Nicolas Ferreyros
Weight-Loss Drug Maridebart Cafraglutide Shows Efficacy in Phase 2 Trial
Prolonged ED Stays, Boarding Times Among Older Adults Underscore Systemic Hospital Strain
FDA Expands Access to Approved CAR T-Cell Therapies by Eliminating REMS
Health Equity & Access Weekly Roundup: June 30, 2025
Patient Materials for Rheumatoid Arthritis Often Miss Crucial Information
Highlighting Disparities in Myeloma Outcomes, the Impacts of Comorbidities
The Role of Real-World Data in Advancing Value-Based Cancer Care: CK Wang, MD
Staffing and Scheduling for Subcutaneous
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Measuring What Matters: Evidence and End Points That Define Disability in MS
Prophylactic Tocilizumab and Sequencing Strategies in the Bispecific Era
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD
Reshaping Rx: Navigating 2025 Drug Pricing Policies—Recording
Medina v Planned Parenthood Case Reinterprets Any Willing Provider Provision: Jennifer Evans, JD
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
The Synergistic Approach: Exploring Potential for Combination Therapies in Fibrosis Control
From ATS 2025: Analysis of Data Supporting PDE4 Inhibition in PPF
Operational Shifts: IV to Subcutaneous
Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD
Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD
PROs Affirm Zongertinib’s Combination of Strong Response Rates With Low Toxicity
Post Hoc Analysis Findings Offer Guidance for Anemia Management in Myelofibrosis: Pankit Vachhani, MD
Potential Health Literacy Resources for Health Plans: A Narrative Review
Population Health Reimagined Through Integrated Care
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
Optimizing Advanced Cancer Therapies and Addressing Logistical, Financial Challenges
Value-Based Care Calls for Putting Novel Therapies Closer to Patients
Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence
The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
